Hospital or health organisation · founded 1980
Brigham and Women's Hospital
Boston, United States · brighamandwomens.org
Part of Tufts University
- Citations, last 5 years
- 746.6k
- Works, last 5 years
- 56.3k
- h-index
- 1,993
- Scientists listed
- 5 466
- Grants since 2016
- 6 437
Grants received
2013–2026 · research · R01
Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state
Soumya Raychaudhuri · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2022 · research · R56
Group VsPLA2 in Innate Immunity and Pulmonary Inflammation
Barbara Balestrieri · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2021 · cooperative agreement · U41
Clinical Genome Resource
David H. Ledbetter · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · training · T32
Training Program in Molecular Hematology
Nancy Berliner · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
SPORE: Targeted Therapies for Glioma - Diversity Supplement
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · research · R01
Neural substrates of diffusion imaging in cognitively aging rhesus monkeys
Marek Kubicki · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2020 · cooperative agreement · U54
Boston Biomedical Innovation Center
David E. Golan · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
SPORE: Targeted Therapies for Glioma - Diversity Supplement
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2022 · research · R01
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers
Raul San Jose Estepar · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2023 · research · R01
Total plasma and IgG glycomes, statin therapy and ASCVD events
Samia Mora · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2020 · research · R01
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
E. Antonio Chiocca · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2026 · research · R01
Use of Correlated Data Methods in Ophthalmology
Bernard A Rosner · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2026 · research · R01
Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state
Soumya Raychaudhuri · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2029 · training · T32
Training Program in Molecular Hematology
Nancy Berliner · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2029 · program · P50
Targeted Therapies for Glioma
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2028 · program · P01
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
E. Antonio Chiocca · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2028 · program · P01
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
Joseph C Glorioso · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2028 · program · P01
Core A - Administrative Core
E. Antonio Chiocca · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2029 · program · P50
Project 2: Druggable dependencies in diffuse midline gliomas
Daphne A. Haas-Kogan · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2029 · program · P50
Project 3: Targeting IDH mutant gliomas
Samuel Kent Mcbrayer · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Biostatistics and Computational Biology Core - Core B
Wendy Beth London · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Pathology - Core A
Keith Lloyd Ligon · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2021 · cooperative agreement · U41
Resource Project
Heidi L Rehm · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Administration - Core C
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2028 · program · P01
Core 1: oHSV Production Core
William F. Goins · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2023 · program · P01
Project 4: Modulating the natural killer cell response to oHSV1 in recurrent human GBM
Michael A Caligiuri · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Administration - Core C
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)
Michael J Eck · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2023 · program · P01
Project 2: Clinical evaluation of a novel oHSV in recurrent human GBM
E. Antonio Chiocca · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2021 · program · P01
Recurrent circadian disruption & pancreatic B-cell responsiveness in older people
Charles A Czeisler · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2021 · program · P01
Adverse metabolic impact of sleep loss in older adults: insulin resistance
Orfeu M Buxton · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2023 · program · P01
Core 3: Biostatistics Core
Soledad A Fernandez · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Dev-Res-Prog-001
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2029 · program · P50
Career Enhancement Program
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)
William G. Kaelin · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2028 · program · P01
Project 4: Awakening immune responses to GBM by enhancing immune cell trafficking and activation with oHSV armed with Cetuximab-CCL5 and anti-CD47 antibody payloads.
Michael A Caligiuri · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Administration - Core C
Tracy T Batchelor · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
Jean Zhao · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)
Daniel P. Cahill · Brigham and Women's Hospital · funded by National Institutes of Health
2013–2024 · program · P50
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
Jean Zhao · Brigham and Women's Hospital · funded by National Institutes of Health
